Business profile

SK Clinical Oy

SK Clinical Oy's registered office is Vanda. It is a limited company. The company was established on 2023-07-06. It operates in the industry of research and experimental development on natural sciences and engineering. In its latest retained statement for 2025-12-31, revenue was €101,329 and operating profit was €10,945.

Claim profileContact details
Business ID 3373181-1ValidUnclaimed company profile

Trusted core data

Public company details from the trade register.

Business ID
3373181-1
Sector
Research and experimental development on natural sciences and engineering
Municipality
Vanda
Company form
Limited company
Registration date
2023-07-06
Business ID registration date
2023-06-20
Business status
Valid
Profile ownership
Unclaimed company profile

Contact and location summary

Visiting address: Rosendalinrinki 3 A 6, 01520, Vanda

About SK Clinical Oy

Financial position and key figures for the company.

SK Clinical Oy's location municipality is Vanda. It is a limited company. The company was established on 2023-07-06. It operates in the industry of research and experimental development on natural sciences and engineering. In its latest retained statement for 2025-12-31, revenue was €101,329 and operating profit was €10,945. The latest retained financial statement for 2025-12-31 shows revenue of €101,329 and profit for the financial year of €8,787. Based on the latest retained statement, revenue growth was +34.3%, operating margin was +10.8%, and equity ratio was +79.2%.

Financial highlights

Key figures from the latest financial period.

Open full statement
Latest financial period

2025-12-31

Imported periods3
PRH parsed3
Profile sourcePRH/XBRL financial statement
Derived indicators
Revenue growth34.3%
Operating margin10.8%
Equity ratio79.2%
Revenue€101,329+€25,893 (+34.3%) vs previous periodPrevious: €75,436
Operating profit (loss)€10,945-€2,481 (-18.5%) vs previous periodPrevious: €13,425
Profit (loss) for the financial year€8,787-€1,830 (-17.2%) vs previous periodPrevious: €10,617
Assets€36,638+€11,259 (+44.4%) vs previous periodPrevious: €25,379
Balance-sheet contextLatest financial period
Cash and bank€18,669Previous: €16,448
Retained earnings€20,221Previous: €11,362
Equity€29,008Previous: €21,980
Liabilities€7,629Previous: €3,399
Current assets€36,638Previous: €25,379
Current liabilities€7,629Previous: €3,399
Revenue trend3 periods
€32,894
2023-12-31
€75,436
2024-12-31
€101,329
2025-12-31
Operating profit (loss) trend3 periods
€15,350
2023-12-31
€13,425
2024-12-31
€10,945
2025-12-31
Profit (loss) for the financial year trend3 periods
€12,350
2023-12-31
€10,617
2024-12-31
€8,787
2025-12-31
Assets trend3 periods
€15,569
2023-12-31
€25,379
2024-12-31
€36,638
2025-12-31

Financial ratios

Financial ratios based on financial statement data. Source: PRH/XBRL-tilinpäätös.

Equity ratioGood
99/100 · Declining
79.2 %2024-12-31: 86.6 %
Current ratioGood
82/100 · Declining
2.45x2024-12-31: 4.84x
Operating profit marginGood
77/100 · Declining
10.8 %2024-12-31: 17.8 %
Ratio history
Ratio2023-12-312024-12-312025-12-31
Equity ratio79.3 %86.6 %79.2 %
Current ratio0.34x4.84x2.45x
Operating profit margin46.7 %17.8 %10.8 %

Registry status and identifiers

Current registry information and identifiers based on YTJ data.

YTJ statusValid
Trade RegisterRegistered
Business ID3373181-1
VAT IDFI33731811
EU IDFIFPRO.3373181-1
MunicipalityVanda
Current registered entries
2023-07-06Registered in Tax Administration (Tax Administration)
2023-07-06Registered in Patent and Registration Office (Trade Register)
2023-07-15VAT-liable for business activity in Tax Administration (VAT Register)
2023-12-08Registered in Tax Administration (Prepayment Register)

Risk certificate

An open-data based company stability and risk signal.

BUSINESS.fi

BUSINESS.fi Luottoluokitus

Profile-specific risk signal based on open data

Automatic gradeNot a credit decision
A3
GoodSK Clinical Oy
Grade unchangedA3 · new analysis 2026-10-17
Model score77/100
Assessment confidenceHigh
Evidence qualityStrong financial evidenceFinancial data included
Financial trajectoryFinancial development has been volatile across multiple domains.
3 comparable periods
RevenueImproving · 2 consecutive periods
ProfitabilityDeteriorating · 2 consecutive periods
SolvencyVolatile
LiquidityVolatile
Peer comparisonSame size nationallyDescriptive comparison – does not change the model score.
1881 peers
Solvency74%
Better than 74% of peers
Profitability63%
Better than 63% of peers
Liquidity79%
Better than 79% of peers
Revenue growth86%
Better than 86% of peers
Financial statement reporting patternRegularBased on observed PRH financial period end and registration dates. This descriptive evidence does not change the v0.14 score.
3 observed filings
Latest registration lag24 days after period end
Typical registration lag32 days after period end
Annual continuity3 consecutive periods
Supporting factors
  • Strong equity ratio
  • Strong operating profitability
  • Healthy short-term liquidity
Risk factors to note
  • Material volatility across multiple financial domains
  • Elevated industry distress context
Rating historyAutomatic assessment developmentChanges are derived from evidence differences between persisted automatic assessments.
5 assessments
A3
2026-10-1777/100 · v0.15
A3 → A3
A3
2026-10-05 15:4677/100 · v0.14
B3 → A3 · +30 points
  • Evidence strengthened: a PRH/XBRL financial statement was added to the assessment (2025-12-31).
  • Assessment confidence: Medium → High.
  • Evidence quality: Registry and statistical evidence → Strong financial evidence.
B3
2026-09-1547/100 · v0.14
B2 → B3 · -5 points
  • Assessment confidence: Low → Medium.
  • Evidence quality: Registry and statistical evidence → Registry and statistical evidence.
  • New risk factor: Sufficient structured financial metrics are not available.
B2
2026-09-1452/100 · v0.12
Oldest retained automatic assessment in this comparison
Automatic model gradeA3
Automatic model snapshot2026-10-17
Automatic model versionopen-risk-grade-v0.15
Financial data included

The grade can use open digital financial statement data together with registry signals.

Verify assessment

Risk context

When sufficient source-backed financial metrics are not available for a Tier 1 assessment, BUSINESS.fi shows registry, industry, and regional context.

Industry riskelevated
48/100

Industry context is elevated based on normalized open statistical inputs.

Age and continuityNuori
35/100

The company has about 3 years of registry continuity.

Registry and status signalsRajallinen
45/100

Registry history, filing recency, and active register markings are still limited or mixed.

Events & news

Verified events and sourced external company news in one timeline.

Risk grade updatedRisk gradeEvidence verified
17 Oct 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade A3.
Risk grade updatedRisk gradeEvidence verified
5 Oct 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B3 → A3.
Risk grade updatedRisk gradeEvidence verified
15 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B3.
Risk grade updatedRisk gradeEvidence verified
14 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B2.

Registry timeline

Trade register notifications shown on a timeline.

5 register eventsLatest event: 2026-01-24

Financial statements availability

Available financial statement periods and PRH source filings.

3 financial statement periodsLatest financial period: 2025-12-31

Profile source and ownership

Profile based on public registry data
BUSINESS.fi has created this profile from public company information. Source data updated 2025-12-31.

This company profile has not been claimed yet

SK Clinical Oy shows public core facts. A company representative can claim the profile, update public information, and access owner tools.